Published in Arch Gen Psychiatry on March 01, 2010
Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry (2012) 2.94
Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry (2013) 2.23
The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry (2013) 2.17
Heartache and heartbreak--the link between depression and cardiovascular disease. Nat Rev Cardiol (2012) 1.55
Functional connectivity in the cognitive control network and the default mode network in late-life depression. J Affect Disord (2012) 1.48
Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression. Biol Psychiatry (2012) 1.25
Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? Neurosci Biobehav Rev (2010) 1.17
fMRI correlates of white matter hyperintensities in late-life depression. Am J Psychiatry (2011) 1.13
The vascular depression hypothesis: an update. Am J Geriatr Psychiatry (2011) 1.09
Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry (2014) 0.97
One-year change in anterior cingulate cortex white matter microstructure: relationship with late-life depression outcomes. Am J Geriatr Psychiatry (2011) 0.95
A model for streamlining psychotherapy in the RDoC era: the example of 'Engage'. Mol Psychiatry (2013) 0.91
Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset. Am J Geriatr Psychiatry (2012) 0.90
Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults. J Alzheimers Dis (2015) 0.90
Frailty and depression in older adults: a high-risk clinical population. Am J Geriatr Psychiatry (2013) 0.90
Neural correlates associated with cognitive decline in late-life depression. Am J Geriatr Psychiatry (2012) 0.89
Resting state functional connectivity and treatment response in late-life depression. Psychiatry Res (2013) 0.89
Diminished performance on neuropsychological testing in late life depression is correlated with microstructural white matter abnormalities. Neuroimage (2012) 0.88
Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial. JAMA Psychiatry (2016) 0.88
Feasibility of studying brain morphology in major depressive disorder with structural magnetic resonance imaging and clinical data from the electronic medical record: a pilot study. Psychiatry Res (2012) 0.88
Speed of processing and depression affect function in older adults with mild cognitive impairment. Am J Geriatr Psychiatry (2013) 0.87
Structural neuroimaging of geriatric depression. Psychiatr Clin North Am (2011) 0.87
Cognitive outcomes after psychotherapeutic interventions for major depression in older adults with executive dysfunction. Am J Geriatr Psychiatry (2013) 0.85
Biological basis of late life depression. Curr Psychiatry Rep (2012) 0.85
Vascular depression prevalence and epidemiology in the United States. J Psychiatr Res (2012) 0.84
Magnetic resonance imaging predictors of treatment response in late-life depression. J Geriatr Psychiatry Neurol (2013) 0.84
Does the Framingham Stroke Risk Profile predict white-matter changes in late-life depression? Int Psychogeriatr (2011) 0.84
The neurobiological pathogenesis of poststroke depression. ScientificWorldJournal (2014) 0.82
A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life Depression. Am J Geriatr Psychiatry (2015) 0.81
Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics. Biochem Pharmacol (2013) 0.80
Cingulum bundle white matter lesions influence antidepressant response in late-life depression: a pilot study. J Affect Disord (2014) 0.80
Imaging small vessel-associated white matter changes in aging. Neuroscience (2013) 0.80
Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression. Am J Geriatr Psychiatry (2013) 0.79
Tissue-specific differences in brain phosphodiesters in late-life major depression. Am J Geriatr Psychiatry (2013) 0.79
Association of gene variants of the renin-angiotensin system with accelerated hippocampal volume loss and cognitive decline in old age. Am J Psychiatry (2014) 0.78
Effects of Kaixinjieyu, a Chinese herbal medicine preparation, on neurovascular unit dysfunction in rats with vascular depression. BMC Complement Altern Med (2015) 0.78
Effects of early life stress on depression, cognitive performance and brain morphology. Psychol Med (2016) 0.78
Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunction. Am J Geriatr Psychiatry (2014) 0.78
The nuances of cognition and depression in older adults: the need for a comprehensive assessment. Int J Geriatr Psychiatry (2013) 0.78
Correlates of treatment response in depressed older adults with bipolar disorder. J Geriatr Psychiatry Neurol (2012) 0.78
Transprocessing: a proposed neurobiological mechanism of psychotherapeutic processing. Ment Illn (2014) 0.77
Vascular burden and cognitive functioning in depressed older adults. Am J Geriatr Psychiatry (2012) 0.77
Personalizing behavioral interventions: the case of late-life depression. Neuropsychiatry (London) (2012) 0.76
A patient-centered research agenda for the care of the acutely ill older patient. J Hosp Med (2015) 0.76
Correlation between Motor Cortex Excitability Changes and Cognitive Impairment in Vascular Depression: Pathophysiological Insights from a Longitudinal TMS Study. Neural Plast (2016) 0.76
Brain Structural Effects of Antidepressant Treatment in Major Depression. Curr Neuropharmacol (2015) 0.76
Reduced comparison speed during visual search in late life depression. J Clin Exp Neuropsychol (2013) 0.76
Recent advances in neuroimaging biomarkers in geriatric psychiatry. Curr Psychiatry Rep (2013) 0.76
Applications of magnetic resonance imaging for treatment-resistant late-life depression. Dialogues Clin Neurosci (2015) 0.75
Brain structural connectivity in late-life major depressive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging (2016) 0.75
SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. Am J Geriatr Psychiatry (2013) 0.75
Treatment of late-life depression: a role of non-invasive brain stimulation techniques. Int Rev Psychiatry (2011) 0.75
APOE ε4 associated with preserved executive function performance and maintenance of temporal and cingulate brain volumes in younger adults. Brain Imaging Behav (2016) 0.75
Vascular depression consensus report - a critical update. BMC Med (2016) 0.75
Intrinsic inter-network brain dysfunction correlates with symptom dimensions in late-life depression. J Psychiatr Res (2016) 0.75
Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression. Am J Geriatr Psychiatry (2015) 0.75
Appetite loss and neurocognitive deficits in late-life depression. Int J Geriatr Psychiatry (2014) 0.75
Treating depression in older adults with dementia. J Am Geriatr Soc (2011) 0.75
Effects of white matter integrity and brain volumes on late life depression in the Framingham Heart Study. Int J Geriatr Psychiatry (2016) 0.75
Organic bases of late-life depression: a critical update. J Neural Transm (Vienna) (2013) 0.75
Microembolism induces anhedonia but no detectable changes in white matter integrity in aged rats. PLoS One (2014) 0.75
Longitudinal Cognitive Outcomes of Clinical Phenotypes of Late-Life Depression. Am J Geriatr Psychiatry (2017) 0.75
Risk factors for late-life depression: A prospective cohort study among older women. Prev Med (2016) 0.75
Random-effects models for longitudinal data. Biometrics (1982) 54.17
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol (1987) 8.48
'Vascular depression' hypothesis. Arch Gen Psychiatry (1997) 6.59
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging (2005) 5.84
The Mini-Mental State Examination. Arch Gen Psychiatry (1983) 5.20
Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke (2004) 4.56
Depression, heart rate variability, and acute myocardial infarction. Circulation (2001) 3.57
The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry (2004) 3.17
Depression and the course of coronary artery disease. Am J Psychiatry (1998) 3.17
Parametric estimate of intensity inhomogeneities applied to MRI. IEEE Trans Med Imaging (2000) 3.09
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation (2005) 2.97
MRI-defined vascular depression. Am J Psychiatry (1997) 2.92
Executive dysfunction and the course of geriatric depression. Biol Psychiatry (2005) 2.56
Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry (2008) 2.53
Depression in adults with diabetes. Diabetes Care (1992) 1.99
White matter changes with normal aging. Neurology (1998) 1.95
Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression. Biol Psychiatry (2006) 1.94
Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry (2006) 1.92
The vascular depression hypothesis: 10 years later. Biol Psychiatry (2006) 1.87
A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med (2002) 1.75
Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry (1995) 1.67
Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care (2006) 1.52
Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke (1999) 1.50
Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry (2008) 1.50
Diffuse microstructural abnormalities of normal-appearing white matter in late life depression: a diffusion tensor imaging study. Biol Psychiatry (2009) 1.46
Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry (2004) 1.46
Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res (2005) 1.39
Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry (1999) 1.37
Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med (1998) 1.35
White-matter integrity predicts stroop performance in patients with geriatric depression. Biol Psychiatry (2006) 1.32
Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry (1990) 1.27
Incidence of silent cerebral infarction in patients with major depression. Stroke (1993) 1.12
A volumetric study of MRI signal hyperintensities in late-life depression. Am J Geriatr Psychiatry (2004) 1.08
Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression--a longitudinal evaluation. Biol Psychiatry (1997) 1.01
Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry (1988) 0.99
Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry (1988) 0.98
Neuroanatomic substrates of depression in the elderly. J Geriatr Psychiatry Neurol (1993) 0.97
Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry (1995) 0.96
Defining remission on the Montgomery-Asberg depression rating scale. J Clin Psychiatry (2004) 0.96
The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients. Am J Geriatr Psychiatry (2002) 0.91
Psychomotor slowing and subcortical-type dysfunction in depression. J Neurol Neurosurg Psychiatry (1987) 0.89
Vascular depression: An archetypal neuropsychiatric disorder. Biol Psychiatry (2006) 0.85
Vascular depression and poststroke depression: where do we go from here? Am J Geriatr Psychiatry (2005) 0.82
New concepts for prevention and treatment of late-life depression. Am J Psychiatry (2001) 0.81
Leukoencephalopathy and major depression: a preliminary report. Psychiatry Res (1992) 0.78
Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med (2007) 9.83
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00
Prediction of individual brain maturity using fMRI. Science (2010) 7.29
The maturing architecture of the brain's default network. Proc Natl Acad Sci U S A (2008) 7.28
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Development of distinct control networks through segregation and integration. Proc Natl Acad Sci U S A (2007) 6.85
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA (2002) 6.72
The WU-Minn Human Connectome Project: an overview. Neuroimage (2013) 5.49
Identification of separable cognitive factors in schizophrenia. Schizophr Res (2004) 5.34
Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med (2008) 5.34
Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med (2007) 4.49
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry (2004) 4.46
The Aging, Demographics, and Memory Study: study design and methods. Neuroepidemiology (2005) 4.44
Unbiased average age-appropriate atlases for pediatric studies. Neuroimage (2010) 4.16
The default mode network and self-referential processes in depression. Proc Natl Acad Sci U S A (2009) 4.05
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol (2012) 3.66
Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med (2010) 3.57
Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry (2012) 3.38
Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int (2008) 3.34
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med (2014) 3.25
Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol (2012) 3.19
APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42. J Neurosci (2010) 2.99
Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull (2007) 2.94
Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry (2012) 2.94
Diffusion-tensor MR imaging of gray and white matter development during normal human brain maturation. AJNR Am J Neuroradiol (2002) 2.93
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol (2011) 2.81
Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Arch Neurol (2008) 2.62
Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression. Biol Psychiatry (2007) 2.61
Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples. Alzheimers Dement (2006) 2.51
Diffusion tensor imaging of adult age differences in cerebral white matter: relation to response time. Neuroimage (2004) 2.42
The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc (2002) 2.42
Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med (2003) 2.41
A theory of cognitive control, aging cognition, and neuromodulation. Neurosci Biobehav Rev (2002) 2.37
Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med (2008) 2.37
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2008) 2.32
Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One (2011) 2.30
Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29
Flexible neural mechanisms of cognitive control within human prefrontal cortex. Proc Natl Acad Sci U S A (2009) 2.26
BOLD correlates of trial-by-trial reaction time variability in gray and white matter: a multi-study fMRI analysis. PLoS One (2009) 2.25
Quantifying data quality for clinical trials using electronic data capture. PLoS One (2008) 2.19
Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med (2004) 2.18
Cognitive control, goal maintenance, and prefrontal function in healthy aging. Cereb Cortex (2007) 2.18
Toward open sharing of task-based fMRI data: the OpenfMRI project. Front Neuroinform (2013) 2.17
Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am J Psychiatry (2005) 2.17
Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood (2010) 2.15
Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J (2007) 2.12
Reducing suicidal ideation in depressed older primary care patients. J Am Geriatr Soc (2006) 2.11
Do hospitals provide lower quality of care to black patients for pneumonia? Crit Care Med (2010) 2.07
Functional connectomics from resting-state fMRI. Trends Cogn Sci (2013) 2.05
MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer (2008) 2.01
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99
Head injury in early adulthood and the lifetime risk of depression. Arch Gen Psychiatry (2002) 1.97
Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology (2012) 1.96
Thalamic shape abnormalities in individuals with schizophrenia and their nonpsychotic siblings. J Neurosci (2007) 1.95
Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression. Biol Psychiatry (2006) 1.94
Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy (2003) 1.93
Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry (2006) 1.92
Depression treatment preferences in older primary care patients. Gerontologist (2006) 1.92
Transport, monitoring, and successful brain MR imaging in unsedated neonates. Pediatr Radiol (2007) 1.92
Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology (2003) 1.87
Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol (2010) 1.87
Diffusion tensor imaging and tractography of human brain development. Neuroimaging Clin N Am (2006) 1.86
Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord (2006) 1.85
Lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from Project LEAD. J Clin Oncol (2006) 1.84
When less is more: TPJ and default network deactivation during encoding predicts working memory performance. Neuroimage (2009) 1.83
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry (2008) 1.81
Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. Radiology (2007) 1.77
Transient BOLD responses at block transitions. Neuroimage (2005) 1.76
Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology (2012) 1.74
Structural abnormalities in gyri of the prefrontal cortex in individuals with schizophrenia and their unaffected siblings. Br J Psychiatry (2010) 1.73
Greater risk of dementia when spouse has dementia? The Cache County study. J Am Geriatr Soc (2010) 1.73
Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. Biol Psychiatry (2006) 1.73
Differences in immune response may explain lower survival among older men with pneumonia. Crit Care Med (2009) 1.71
Brain network connectivity in individuals with schizophrenia and their siblings. Biol Psychiatry (2010) 1.71
Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis (2008) 1.67
Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A (2011) 1.67
Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium. Schizophr Bull (2011) 1.67
Prefrontal mechanisms for executive control over emotional distraction are altered in major depression. Psychiatry Res (2008) 1.66
Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res (2002) 1.65
Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol (2011) 1.63
Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother (2003) 1.61
Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study. J Am Geriatr Soc (2010) 1.60
T(2) relaxometry of normal pediatric brain development. J Magn Reson Imaging (2009) 1.60
Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol (2002) 1.60
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry (2010) 1.59
Low-frequency repetitive transcranial magnetic stimulation to the temporoparietal junction for tinnitus. Arch Otolaryngol Head Neck Surg (2011) 1.58
Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am J Psychiatry (2004) 1.55